Institut de Recerca Biomèdica de Barcelona

Institut de Recerca Biomèdica de Barcelona
Name	Institut de Recerca Biomèdica de Barcelona
Native name	Institut de Recerca Biomèdica de Barcelona
Established	1995
Type	Biomedical research institute
Location	Barcelona, Catalonia, Spain
Coordinates	41.3851°N 2.1734°E
Director	Joan-Ramon Marsal
Faculty	Multidisciplinary investigators

Institut de Recerca Biomèdica de Barcelona is a biomedical research center based in Barcelona, Catalonia, Spain, focused on translational research in molecular biology, clinical investigation, and public health. The institute brings together investigators from universities, hospitals, and research centers to pursue projects spanning basic science to patient-oriented studies and technology transfer. As a hub in the Barcelona biomedical ecosystem, it interfaces with hospitals, universities, foundations, and international consortia to accelerate discovery and application.

History

The institute was founded in 1995 amid regional initiatives linked to Parc de Recerca Biomèdica de Barcelona, Universitat de Barcelona, Hospital Clínic de Barcelona, Fundació Clínic per a la Recerca Biomèdica, and the Institut Català de la Salut to consolidate research capacity in Catalonia. Early collaborations involved researchers associated with Centro Nacional de Investigaciones Oncológicas, Consejo Superior de Investigaciones Científicas, Hospital Universitari Vall d'Hebron, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), establishing lines in immunology, neuroscience, and infectious disease. Over successive decades the institute expanded through partnerships with Pompeu Fabra University, Barcelona Supercomputing Center, Casa Àsia, and philanthropic entities such as Fundació La Caixa and Fundació Bancària "la Caixa", adapting to priorities set by European Research Council programs and national initiatives like Plan Nacional de I+D+i.

Organization and Governance

Governance integrates representatives from academic and clinical stakeholders including Universitat Autònoma de Barcelona, Universitat de Barcelona Faculty of Medicine, Hospital del Mar Medical Research Institute (IMIM), and municipal authorities from Ajuntament de Barcelona. The board includes members linked to Ministerio de Ciencia e Innovación, Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), and private sector partners such as Grifols and Rovi. Scientific leadership coordinates with principal investigators affiliated with programs at European Molecular Biology Laboratory, Wellcome Trust, and Gates Foundation-funded consortia, while administrative units liaise with European Commission funding offices, Horizon 2020 project management teams, and ethics committees associated with Comitè Ètic d'Investigació Clínica (CEIC).

Research Programs and Institutes

Research spans molecular genetics, immunology, neuroscience, and translational oncology with groups linked to Centro de Investigación Biomédica en Red (CIBER), Program for Molecular Medicine (PMM), and thematic networks such as Red de Investigación en SIDA (RIS). Investigators collaborate with teams at Institut Pasteur, Max Planck Society, Johns Hopkins University, Harvard Medical School, and Karolinska Institutet on projects in genomics, metabolomics, and stem cell biology. Programmatic activities include cohorts coordinated with Barcelona Institute for Global Health (ISGlobal), vaccine research aligned with Coalition for Epidemic Preparedness Innovations (CEPI), and neurodegeneration efforts connected to Alzheimer's Association initiatives.

Collaborations and Partnerships

The institute maintains partnerships with clinical centers such as Hospital Clínic de Barcelona, Hospital Sant Pau, and Hospital Germans Trias i Pujol (Can Ruti), and academic partners including Pompeu Fabra University, Universidad de Barcelona, and Universitat Autònoma de Barcelona. International consortia link the institute to European Research Area projects, collaborations with National Institutes of Health, bilateral programs with Fundación Bill y Melinda Gates, and industry alliances with Novartis, GlaxoSmithKline, and Roche. Public–private ventures include translational pipelines with CataloniaBio & HealthTech and technology transfer offices coordinated with Biocat and regional development agencies.

Facilities and Resources

Infrastructure comprises laboratory complexes, biosafety level facilities, high-throughput sequencing cores, and imaging platforms shared with Barcelona Supercomputing Center and Centre Nacional d'Anatomia Patològica. Core resources include mass spectrometry units, flow cytometry facilities, animal facilities compliant with European Directive 2010/63/EU, and biobanks integrated into networks such as BBMRI-ERIC. Computational support is provided via partnerships with Barcelona Supercomputing Center (BSC), bioinformatics groups collaborating with European Bioinformatics Institute (EMBL-EBI), and data management aligned to General Data Protection Regulation frameworks for clinical research.

Funding and Grants

Funding sources include competitive awards from European Research Council, grants from Ministerio de Ciencia e Innovación, contracts with Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), and philanthropic support from Fundació "la Caixa" and private donors. The institute secures project funding through Horizon Europe calls, bilateral programs with National Institutes of Health (NIH), and collaborations with industry partners such as Grifols and Roche for clinical trials. Additional income derives from technology transfer, patents registered with European Patent Office, and participation in public procurement frameworks tied to Comunitat Autònoma de Catalunya initiatives.

Impact and Notable Achievements

Notable achievements include contributions to understanding mechanisms in neurodegenerative disorders alongside groups at Institut de Neurociències, advances in immunotherapy developed in collaboration with Institut d'Oncologia de Barcelona (VHIO), and participation in multicenter vaccine trials coordinated with European Medicines Agency advisors. The institute has hosted researchers awarded European Research Council Starting Grants, Marie Skłodowska-Curie Actions fellowships, and collaborations that informed policy at Department de Salut de la Generalitat de Catalunya. Publications in journals such as Nature, Science, Cell, and The Lancet have resulted from its programs, and spin-off companies created with support from Biocat and Barcelona Activa have translated laboratory discoveries to diagnostics and therapeutics.

Category:Research institutes in Catalonia